San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of a new AVR(R) 8-bit microcontroller for automotive LIN networking applications. The ATtiny87 is the second device of a LIN-dedicated low pin-count family specially optimized for cost-sensitive LIN ...
Milton Keynes, England (ots/PRNewswire) - The world-leading plasma lamp technology developed by UK lighting company Ceravision has been further enhanced through a joint development programme with Swedish microwave engineering firm Dipolar AB. The collaboration has produced a power supply that is ultra-efficient, very cost-effective and allows the use of ...
San Jose, California (ots/PRNewswire) - - New Device Offers Immediate Cost Savings to Customer with Low Memory Requirements Atmel(R) Corporation (Nasdaq: ATML) announced today the availability of a new System-in-Package (SiP) solution for LIN automotive networking applications. The ATA6616, featuring ...
San Jose, California (ots/PRNewswire) - - US$19.99 kit allows developers and potential customers to evaluate the capabilities of CryptoAuthentication for preventing counterfeiting of medical and electronic consumables, maintain authenticity of end-product firmware, and protect sensitive transmitted data. ...
Cali, Colombia (ots/PRNewswire) - Transtel Intermedia S.A. (the "Company") today announced the results of its (i) private offer to exchange, for each US$100,000 of principal amount (excluding accrued but unpaid interest) of its outstanding 12% Senior Notes due 2016 (the "Existing Notes"), one of its units ...
DAIICHI SANKYO EUROPE GmbH and SHARE
Munich (ots/PRNewswire) - - Investigating the Real Burden of Hypertension, Addressing the Challenges of Getting to Blood Pressure Goal and SHARE(ing) the Knowledge (http://www.SHARE-hypertension.com) The SHARE steering committee announce the launch of Supporting Hypertension Awareness & Research Europe-wide (SHARE) program on World Hypertension Day 2009 ...
Ingelheim, Germany (ots/PRNewswire) - - For Non-US Media Only - Boehringer Ingelheim's LUX-Lung Programme Moves Forward With New Studies Revealing the Potential of BIBW 2992 in Personalising Lung Cancer Care - The First Presentation of Data From BIBF 1120 in Ovarian Cancer Boehringer Ingelheim ...
London (ots/PRNewswire) - Perenco Ecuador Limited ("Perenco") announced today that on May 8, 2009, a three member international arbitration tribunal constituted under the auspices of the International Centre for the Settlement of Investment disputes ("ICSID") unanimously ordered that the Republic of Ecuador and Empresa Estatal Petroleos del Ecuador ("Petroecuador") were restrained from instituting or further ...
Basel, Switzerland (ots/PRNewswire) - - EMBARGOED: Not for publication until: 14 May at 23:00 BST More than 500 scientific abstracts to be presented across 20 types of cancers. Results could significantly improve the way cancer is treated for patients with inoperable stomach cancer; advanced melanoma; lung and breast cancers. To view the Multimedia News ...
San Jose, California (ots/PRNewswire) - - AT73C240 integrates 20-bit Stereo Audio DAC with 90dB dynamic range, together with 1W Power Amplifier Atmel(R) Corporation (Nasdaq: ATML) announced today the release of its AT73C240 Audio Companion IC for portable multimedia applications. Manufactured on Atmel's ...
Maurepas, France (ots/PRNewswire) - Berberine EURL (held by Mr. Frederic Marchal), Amiral Gestion, B&G SARL, Financier John Beslay and Mr. Jean-Sebastien Beslay, current reference shareholders (hereafter referred to as "Reference Shareholders")in Inventoriste with 87.17% of shares and voting rights, granted, ...
Cali, Colombia (ots/PRNewswire) - Transtel Intermedia S.A. (the "Company") today announced that it has amended the terms of its (i) private offer to exchange, for each US$100,000 of principal amount (excluding accrued but unpaid interest) of its outstanding 12% Senior Notes due 2016 (the "Existing Notes"), one of its units (the "New Units"), each New Unit ...
New York (ots/PRNewswire) - - Level 3 Teams with High-Performance Transporter Aspera to Expedite Large-File Content Delivery Level 3 Communications, Inc. (Nasdaq: LVLT) today announced that it will offer its Content Delivery Network (CDN) customers a new High-Speed Content Upload service that enables rapid uploading of multimedia content to the Level 3 Origin Storage Platform. Level 3 has augmented its ...
DNP Green Technology; Bioamber
Princeton, New Jersey (ots/PRNewswire) - DNP Green Technology, one of the two shareholders of Bioamber, is pleased to announce a scientific agreement with the National Research Council of Canada Biotechnology Research Institute (NRC-BRI). This partnership aims to develop a second-generation technology for the production of bio-based succinic acid, which is used ...
Paris (ots/PRNewswire) - Valeo today announced that the Group's 30,000 Internet-connected employees now have access to a new communication and collaborative working platform based on Google Apps Premier Edition and supported by Capgemini. The progressive roll-out of the new system is giving employees access to a suite of online products which will ...
Cali, Colombia (ots/PRNewswire) - Transtel Intermedia S.A. (the "Company") today announced that it has extended the expiration of its (i) private offer to exchange, for each US$100,000 of principal amount (excluding accrued but unpaid interest) of its outstanding 12% Senior Notes due 2016 (the ...
Cali, Colombia (ots/PRNewswire) - Transtel Intermedia S.A. (the "Company") today announced that it has amended the terms of its (i) private offer to exchange, for each US$100,000 of principal amount (excluding accrued but unpaid interest) of its outstanding 12% Senior Notes due 2016 (the "Existing Notes"), one of its units (the "New Units"), each New Unit ...
Collegeville, Pennsylvania (ots/PRNewswire) - -- Candidate vaccine designed to protect against the 13 most prevalent serotypes associated with pneumococcal disease -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) granted priority review to the company's Biologic License Application ...
Amsterdam Molecular Therapeutics B.V
Amsterdam (ots/PRNewswire) - Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today the treatment of the first patient in a preregistration clinical trial with Glybera(TM). This gene therapy product targets lipoprotein lipase deficiency (LPLD), a seriously debilitating and potentially lethal disease. The randomized controlled trial has been designed to ...
Montreal (ots/PRNewswire) - - Taking Advantage of the Train at Home Concept, Pegasus Airlines Trains at IFTC Istanbul and Becomes IFTC's First Golden Airline Mileage Customer in Less than a Year IFTC Istanbul, the training arm of the Gozen Holding, today announced that Pegasus Airlines has reached 3,000 hours of simulator training time making the Turkish airline the largest customer of IFTC. The ...
San Jose, California (ots/PRNewswire) - - Leading Research Firm Ranks Companies by Combined Total Revenues, Revenue Growth and Product Sales Atmel(R) Corporation (Nasdaq: ATML) has been named by Gartner, Inc. in its most recent 2009 market research (Source: Gartner, Semiconductor Industry Worldwide Annual Market Share: Database April 2009) as the fastest ...
Feltham, England (ots/PRNewswire) - - Innovative Powder Formulation of Metformin Designed to Facilitate Adherence by Increasing Patient Choice in the Treatment of Type 2 Diabetes, Now Available in France and the United Kingdom Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced ...
Oslo (ots/PRNewswire) - ODS-Petrodata has recently revised its MSS Cost Index for field development projects based on a worsening outlook for the global economy, commodity prices and contractor margins. Global field development and pipeline construction investment, not including drilling, is expected to decline by 15 percent in 2009 relative to 2008, ...
Mumbai (ots/PRNewswire) - - Evaluation Based on Completeness of Vision and Ability to Execute Tata Communications, a leading provider of a new world of communications, today announced it has been positioned by industry analyst firm Gartner, Inc. in the Challengers quadrant of its "Magic Quadrant for ...
Ingelheim, Germany (ots/PRNewswire) - - New Study Shows That Mirapexin(R)/Sifrol(R) (Pramipexole) Relieves Depressive Symptoms of Parkinson's Disease (PD), a Common Non-Motor Symptom Affecting PD Patients' Quality of Life - For Non-US Healthcare Media To view the Multimedia News Release, go ...
Shanghai (ots/PRNewswire) - - New modern gasoline turbo technology sets new standards in performance and fuel efficiency Honeywell (NYSE: HON) announced that its turbo technologies are fitted on three world-class gasoline vehicles from BMW launched at the 2009 Shanghai Auto Show, including a world ...
Shanghai (ots/PRNewswire) - - World's Fastest Growing Auto Market Looks to Turbocharged Engines to Deliver Energy Efficiency without Sacrificing Performance Honeywell (NYSE: HON) announced that its gasoline and diesel turbochargers are featured on more than 20 passenger vehicles at the 2009 Shanghai Auto Show, including 15 turbo launches for new passenger ...
Cali, Colombia (ots/PRNewswire) - Transtel Intermedia S.A. (the "Company") today announced that it has extended the expiration of and supplemented the terms of its (i) private offer to exchange, for each US$100,000 of principal amount (excluding accrued but unpaid interest) of its outstanding 12% Senior Notes ...
Ingelheim, Germany (ots/PRNewswire) - - Data for the Once Daily Mirapexin(R)/Sifrol(R) (Pramipexole) Formulation Under Development Show Efficacy, Safety and Tolerability Outcomes Comparable to the Current Immediate Release Formulation for the Treatment of Parkinson's Disease For non-US Healthcare Media ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Media outside the U.S.A. New data presented today at the 61st Annual Meeting of the American Academy of Neurology (AAN), in Seattle, U.S.A. show that augmentation did not significantly differ in RLS patients treated with Mirapexin(R) /Sifrol(R) ...